Clinical Trial: Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Head and Neck Squamous Cell Carcinoma
Study Type: INTERVENTIONAL
Official Title: Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer
Brief Summary:
This phase I trial tests the safety and effectiveness of indium In 111 panitumumab (111In-panitumumab) for identifying the first lymph nodes to which cancer has spread from the primary tumor (sentinel lymph nodes) in patients with head and neck squamous cell carcinoma (HNSCC) undergoing surgery.The most important factor for survival for many cancer types is the presence of cancer that has spread to the lymph nodes (metastasis).Lymph node metastases in patients with head and neck cancer reduce the 5-year survival…
Read more